Steve brings deep experience in strategic transactions to Werewolf at this critical time,” said Daniel J. Hicklin, Ph.D., President and Chief Executive Officer of Werewolf Therapeutics. “Werewolf is ...

The FDA will begin replacing animal testing in the development of monoclonal antibody therapies and other drugs with ...

Johnson & Johnson MedTech, a global leader in surgical technologies and solutions, today announced completion of the first cases in the clinical trial for the OTTAVAtm Robotic Surgical System. The ...

Werewolf Therapeutics, Inc. (the "Company" or "Werewolf") (Nasdaq: HOWL), an innovative biopharmaceutical company pioneering the development of conditionally ...

OmniAb, Inc. will report financial results for the three months ended March 31, 2025 after the close of the U.S. financial markets on Thursday, May 8, 2025, and will hold a conference call that same ...

Learn more about whether Amarin Corporation plc or CRISPR Therapeutics AG is a better investment based on AAII's A+ Investor ...

We recently published a list of Tech Firms Dominate Monday’s 10 Worst Performers. In this article, we are going to take a ...

We recently published a list of Gold, Biopharma Firms Dominate Friday’s 10 Top Performing Stocks. In this article, we are ...

The Pharmacy and Poisons Committee ... procedure aims to reduce repeated local reviews of a study application. For investigational new drug (IND) studies, submission can be done via the JIRB ...

Marcia currently manages the pharmacy benefit strategy and drug ... infectious diseases, investigational drug research, cancer chemotherapy, gastro-intestinal, anesthetics, pain, respiratory ...

The Indiana Statehouse’s 2025 legislative session included discussion on a variety of topics such as property tax reform, ...